Financial Gravity Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Financial Gravity Asset Management's NVO Position: Q1 2026 in Review
Financial Gravity Asset Management increased its Novo Nordisk (NVO) stake by 13% in Q1 2026, buying an estimated $277K and bringing the position to 51,858 shares worth $1.91M. The position accounts for 0.34% of the portfolio, ranked #68.
Financial Gravity Asset Management first reported a position in NVO in Q1 2018 and has held it in 17 quarters since. The position peaked at $3.34M in Q2 2024. 1,278 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Financial Gravity Asset Management held 51,858 shares of Novo Nordisk worth $1.91M as of Q1 2026.
- Financial Gravity Asset Management bought 5,838 Novo Nordisk shares in Q1 2026, an estimated $277K.
- Novo Nordisk made up 0.34% of Financial Gravity Asset Management's portfolio in Q1 2026, its #68 holding.
- Financial Gravity Asset Management first reported a position in Novo Nordisk in Q1 2018 and has held it in 17 quarters since.
- Financial Gravity Asset Management's Novo Nordisk position peaked at $3.34M in Q2 2024.
- 1,278 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.